Find out about Deprescribing Guidelines

Deprescribing guidelines support health care providers and patients in reducing or stopping medications that may be harmful or no longer needed.

Find out about EMPOWER brochures

EMPOWER brochures help patients understand the rationale for deprescribing certain medications and explain why it is important to talk to a health care provider about deprescribing

Find out about deprescribing research

Deprescribing research explores new tools for polypharmacy management, engaging patients in their care, and more.

Reducing medications safely to meet life’s changes

What medications were good then might not be the best choice now. Deprescribing is the planned process of reducing or stopping medications that may no longer be of benefit or may be causing harm. The goal is to reduce medication burden or harm while improving quality of life.

Be part of the change for a better quality of life

Patients

Learn about deprescribing and check out resources to help you discuss deprescribing with your health care provider.

Health Care Providers

Get comfortable deprescribing with tools and resources, case reports and testimonials, and relevant publications.

Researchers

Find out about ongoing research at Bruyère Research Institute and the University of Montreal and join the conversation to share your own research.

Sign up for the Bruyère Deprescribing Guidelines Research Team’s newsletter

To receive deprescribing.org updates and news, subscribe to our periodic newsletter

As the population ages, older Canadians are living with multiple chronic conditions. In 2016, 35% of community-dwelling seniors had chronic use of 5 or more different drug classes.

Canadian Institute for Health Information. Drug use among seniors 2016.

Inappropriate prescriptions are known to pose health risks for older adults, leading to unnecessary hospitalisations and undue cost.

Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. The New England Journal of Medicine. 2011;365(21):2002-12

“It is an art of no little importance to administer medicines properly; but it is an art of much greater and more difficult acquisition to know when to suspend or altogether omit them.”

Philippe Pinel 1745-1826

What’s happening?

Evaluation of a Deprescribing Guideline Mobile Application

The four evidence-based deprescribing guidelines and algorithms produced through the leadership of the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, and the guideline developed through an NHMRC-ARC Dementia Research Fellowship have been built...

The Unsung Role of the Pharmacist in Patient Health

January 28, 2019 - We know many people end up with a risky pileup of prescribed medications. Many efforts have been made, with varied success, to correct this problem. Yet we’ve usually focused on physician behavior, when there’s another powerful lever: pharmacists....

Acetylcholinesterase inhibitors and memantine deprescribing guideline

Using the evidence-based deprescribing guideline method established through the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, Dr. Reeve developed an Australian/Canadian focused prescribing guideline for acetylcholinesterase inhibitors and...

Keep up with the latest